GFC Life Science Co., Ltd (KOSDAQ:388610)

GFC Life Science Revenue

GFC Life Science had revenue of 5.04B KRW in the quarter ending March 31, 2026, with 12.24% growth. This brings the company's revenue in the last twelve months to 18.26B, up 7.64% year-over-year. In the year 2025, GFC Life Science had annual revenue of 17.71B with 5.42% growth.

• Revenue (ttm): 18.26B
• Revenue Growth: +7.64%
• P/S Ratio: 1.84
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 33.69B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	17.71B	910.25M	5.42%
Dec 31, 2024	16.80B	3.07B	22.33%
Dec 31, 2021	13.74B	412.37M	3.09%
Dec 31, 2020	13.32B	1.42B	11.89%
Dec 31, 2019	11.91B	3.23B	37.21%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 8, 2026

Data Sources Report a data error